ERBB2 and breast cancer: Breast cancer is a heterogeneous disease that can be classified according to the presence of transmembrane receptors (i.e., hormonal receptors and human epidermal growth factor receptor 2 [HER2]) as assessed by immunohistochemistry analyses.